Literature DB >> 9687406

vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans.

M Ligozzi1, G Lo Cascio, R Fontana.   

Abstract

We report on the cloning and sequencing of the vanA gene cluster present in the glycopeptide-resistant clinical isolate Bacillus circulans VR0709 (R. Fontana, M. Ligozzi, C. Pedrotti, E. M. Padovani, and G. Cornaglia, Eur. J. Clin. Microbiol. Infect. Dis. 16:473-474, 1997). The presence of a vanA-related gene in VR0709 was demonstrated in a PCR assay which permitted the specific amplification of an internal segment of vanA. Southern blotting suggested that the vanA gene was located in the chromosome in a 7. 6-kb EcoRI fragment. DNA sequence analysis revealed the presence of all seven genes of the vanA cluster (vanR, vanS, vanH, vanA, vanX, vanY, and vanZ). The degree of identity between homologous proteins encoded by Tn1546 and the chromosome of B. circulans VR0709 ranged from 87 to 95%. Neither PCR nor Southern blotting with specific primers and probes, respectively, showed the presence of open reading frames (ORFs) 1 and 2 which encode the transposase and the resolvase of Tn1546, respectively, the transposon found to carry the vanA gene cluster in enterococci. Determination of the sequences of the flanking regions of the van gene cluster of B. circulans revealed perfect inverted repeats of 10 bp which delineated a 9.2-kb region containing the van gene cluster and an ORF which encoded a putative protein (178 residues) which displayed a low level of identity (28%) to the resolvase of Tn1546. These results suggest that glycopeptide resistance in B. circulans VR0709 is associated with the acquisition of a vanA gene cluster which shows a high degree of homology with that of enterococci. In B. circulans, however, the cluster is not carried by Tn1546 and is borne by the chromosome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687406      PMCID: PMC105734     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

Review 2.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States.

Authors:  S Handwerger; J Skoble; L F Discotto; M J Pucci
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 4.  Genetics and mechanisms of glycopeptide resistance in enterococci.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

5.  Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147.

Authors:  A Brisson-Noël; S Dutka-Malen; C Molinas; R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

6.  Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome.

Authors:  R Quintiliani; P Courvalin
Journal:  FEMS Microbiol Lett       Date:  1994-06-15       Impact factor: 2.742

7.  Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus.

Authors:  W C Noble; Z Virani; R G Cree
Journal:  FEMS Microbiol Lett       Date:  1992-06-01       Impact factor: 2.742

8.  Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; M Weber; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

9.  Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis.

Authors:  T I Nicas; C Y Wu; J N Hobbs; D A Preston; N E Allen
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

10.  Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity.

Authors:  T D Bugg; S Dutka-Malen; M Arthur; P Courvalin; C T Walsh
Journal:  Biochemistry       Date:  1991-02-26       Impact factor: 3.162

View more
  10 in total

1.  Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil.

Authors:  Luca Guardabassi; Bruno Perichon; Jean van Heijenoort; Didier Blanot; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Members of the genera Paenibacillus and Rhodococcus harbor genes homologous to enterococcal glycopeptide resistance genes vanA and vanB.

Authors:  L Guardabassi; H Christensen; H Hasman; A Dalsgaard
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Pathogenesis of gram-positive bacterial endophthalmitis.

Authors:  M C Callegan; M C Booth; B D Jett; M S Gilmore
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

4.  Vancomycin and maltodextrin affect structure and activity of Staphylococcus aureus biofilms.

Authors:  Mia Mae Kiamco; Erhan Atci; Qaiser Farid Khan; Abdelrhman Mohamed; Ryan S Renslow; Nehal Abu-Lail; Boel A Fransson; Douglas R Call; Haluk Beyenal
Journal:  Biotechnol Bioeng       Date:  2015-09-02       Impact factor: 4.530

Review 5.  New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides.

Authors:  Truc T Tran; Sara Gomez Villegas; Samuel L Aitken; Susan M Butler-Wu; Alex Soriano; Brian J Werth; Jose M Munita
Journal:  Antimicrob Agents Chemother       Date:  2022-04-27       Impact factor: 5.938

6.  Multiple antibiotic resistance gene transfer from animal to human enterococci in the digestive tract of gnotobiotic mice.

Authors:  C Moubareck; N Bourgeois; P Courvalin; F Doucet-Populaire
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

7.  Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice.

Authors:  Aline Launay; Susan A Ballard; Paul D R Johnson; M Lindsay Grayson; Thierry Lambert
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

8.  Evaluation of the iNtRON VRE vanA/vanB real-time PCR assay for detection of vancomycin-resistant enterococci.

Authors:  Hee Jae Huh; Mi-Ae Jang; Ja Young Seo; Ji-Youn Kim; Chang-Seok Ki; Jong-Won Kim; Nam Yong Lee
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

9.  Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics.

Authors:  Vishma Pratap Sur; Aninda Mazumdar; Vladimir Vimberg; Tommaso Stefani; Ladislav Androvic; Lucie Kracikova; Richard Laga; Zdenek Kamenik; Katerina Komrskova
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

10.  First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia.

Authors:  Diana Panesso; Sigifredo Ospina; Jaime Robledo; María Claudia Vela; Julieta Peña; Orville Hernández; Jinnethe Reyes; César A Arias
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.